ReviewTherapeutic advances in gastroenterology2020

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review.

William D Chey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.